Keytruda Market Size, Revenue, Trends, and Growth Forecast 2026-2033 The Keytruda market is experiencing notable shifts influenced by evolving industry dynamics and therapeutic advancements. As a leading immunotherapy drug, Keytruda remains a focal point in oncology despite emerging challenges. Market Size and Overview The Global Keytruda Market size is estimated to be valued at USD 29.95 billion in 2026 and is expected to decline to USD 24.37 billion by 2033, exhibiting a compound annual growth rate (CAGR) of -2.9% from 2026 to 2033. Despite the moderate contraction, market dynamics such as patent expirations, emerging biosimilars, and evolving treatment protocols are reshaping the industry size and market share. Keytruda Market Report indicates a shifting competitive landscape with increased emphasis on tailored therapies and cost-effectiveness, impacting overall market revenue and growth strategies. Keytruda Market - https://www.coherentmarketinsights.com/industry-reports/keytruda-market #KeytrudaMarket #ImmunotherapyMarket #OncologyDrugs #CancerTreatmentMarket #PD1Inhibitors #PersonalizedMedicine #CoherentMarketInsights